If you assume they have to pay capital gains taxes on Exito/Cnova/divestments, this would be max a $0.30 hit to the price target. However, CBD's cost basis in Exito is significantly higher than what they will sell the shares for (~$2.5B, if I recall correctly) and they have another $800m in tax assets they could likely use to offset most of these gains.
Would there be any taxes related to monetization of XETO and the French asset .
Hi Steve, thanks for the questions.
If you assume they have to pay capital gains taxes on Exito/Cnova/divestments, this would be max a $0.30 hit to the price target. However, CBD's cost basis in Exito is significantly higher than what they will sell the shares for (~$2.5B, if I recall correctly) and they have another $800m in tax assets they could likely use to offset most of these gains.
So they don't have a tax of .3 right?